NeoGenomics, Inc. (NASDAQ:NEO)

PRESS RELEASE

published on 12/28/2023 at 14:10, 2 years 3 months ago

NeoGenomics to Appeal Ruling
NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
PRESS RELEASE

published on 12/05/2023 at 14:00, 2 years 4 months ago

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial

NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
PRESS RELEASE

published on 11/14/2023 at 13:00, 2 years 4 months ago

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
PRESS RELEASE

published on 11/06/2023 at 22:05, 2 years 5 months ago

NeoGenomics Reports Third Quarter 2023 Results
PRESS RELEASE

published on 10/24/2023 at 13:00, 2 years 5 months ago

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
PRESS RELEASE

published on 10/17/2023 at 15:20, 2 years 5 months ago

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

Published on 04/09/2026 at 16:00, 56 minutes ago

Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 2 hours 16 minutes ago

Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 2 hours 56 minutes ago

Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 3 hours 26 minutes ago

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 3 hours 26 minutes ago

ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel

View all ACCESSWIRE

Published on 04/09/2026 at 15:59, 56 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:57, 59 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:40, 1 hour 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 1 hour 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 15:39, 1 hour 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The

View all EQS

Published on 04/09/2026 at 15:57, 58 minutes ago

Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 9 hours 56 minutes ago

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 22 hours 54 minutes ago

Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 17:45, 23 hours 11 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 04/08/2026 at 12:58, 1 day 3 hours ago

EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH

View all LES ECHOS COMFI WIRE

News